CAPRICOR THERAPEUTICS, INC. CAPR
CAPRICOR THERAPEUTICS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -191.1% | -95.6% | -1142.2% | -8549.9% | -4412.6% | -769.5% | -917.0% | -482.4% | -424.6% |
| Net margin | — | -181.7% | -88.5% | -1116.1% | -8175.9% | -4401.9% | -760.4% | -908.9% | 91.2% | -470.3% |
| FCF margin | — | -184.8% | -106.9% | 112.2% | -7352.3% | -3417.4% | -678.7% | -848.3% | -534.9% | -400.0% |
| Return on assets | -29.5% | -23.7% | -37.9% | -57.9% | -48.4% | -39.4% | -68.8% | -164.3% | 14.9% | -100.3% |
| Return on equity | -34.4% | -27.8% | -98.6% | -246.2% | -63.8% | -48.4% | -111.7% | -329.1% | 21.7% | 469.8% |
| Current ratio | 9.01 | 7.77 | 1.63 | 1.82 | 8.82 | 11.33 | 11.74 | 6.75 | 9.40 | 3.70 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.